Access Investment Management LLC raised its stake in Genpact Limited (NYSE:G - Free Report) by 44.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 212,875 shares of the business services provider's stock after purchasing an additional 65,070 shares during the period. Genpact accounts for 2.5% of Access Investment Management LLC's holdings, making the stock its 13th biggest holding. Access Investment Management LLC owned 0.12% of Genpact worth $8,347,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in G. CWM LLC lifted its position in Genpact by 160.8% in the 2nd quarter. CWM LLC now owns 952 shares of the business services provider's stock valued at $31,000 after acquiring an additional 587 shares in the last quarter. Versant Capital Management Inc boosted its position in shares of Genpact by 4,717.8% during the second quarter. Versant Capital Management Inc now owns 2,168 shares of the business services provider's stock valued at $70,000 after buying an additional 2,123 shares during the last quarter. Massmutual Trust Co. FSB ADV grew its holdings in Genpact by 54.3% during the second quarter. Massmutual Trust Co. FSB ADV now owns 2,797 shares of the business services provider's stock worth $90,000 after buying an additional 984 shares in the last quarter. Venturi Wealth Management LLC raised its position in Genpact by 74.6% in the 3rd quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider's stock valued at $103,000 after buying an additional 1,121 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in Genpact by 221.3% during the 3rd quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider's stock valued at $131,000 after acquiring an additional 2,293 shares in the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
Genpact Price Performance
Shares of NYSE G traded up $0.72 during midday trading on Monday, hitting $46.66. 1,418,006 shares of the company's stock were exchanged, compared to its average volume of 1,328,310. The business's fifty day moving average price is $39.18 and its two-hundred day moving average price is $35.68. The company has a market cap of $8.31 billion, a price-to-earnings ratio of 12.82, a PEG ratio of 1.92 and a beta of 1.13. The company has a current ratio of 1.89, a quick ratio of 1.89 and a debt-to-equity ratio of 0.52. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $47.98.
Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, August 8th. The business services provider reported $0.69 EPS for the quarter, beating analysts' consensus estimates of $0.64 by $0.05. Genpact had a return on equity of 22.09% and a net margin of 14.22%. The business had revenue of $1.18 billion for the quarter, compared to analysts' expectations of $1.15 billion. As a group, research analysts forecast that Genpact Limited will post 2.85 EPS for the current fiscal year.
Genpact Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 9th will be paid a $0.1525 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.31%. Genpact's dividend payout ratio (DPR) is 16.76%.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on G shares. Robert W. Baird boosted their target price on Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research note on Friday. TD Cowen upped their price objective on Genpact from $40.00 to $45.00 and gave the company a "hold" rating in a research note on Friday. JPMorgan Chase & Co. raised their target price on Genpact from $35.00 to $43.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. BMO Capital Markets boosted their price target on shares of Genpact from $38.00 to $42.00 and gave the stock a "market perform" rating in a report on Monday, August 12th. Finally, Needham & Company LLC raised their price target on shares of Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a research note on Monday. Eight equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $42.33.
Get Our Latest Research Report on G
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.